Position in GMAB
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,298,008
+$75,033 QoQ
Shares Held
48,379
+21.8% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2023
7 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in GMAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Vident Advisory, LLC holds $44,934,093 across 44 Biotechnology names. GMAB ranks #7 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
16,063 | $7,172,769 | |
| 2 | EXEL |
Exelixis, Inc.
|
148,830 | $6,383,317 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
23,032 | $4,354,199 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,449 | $2,664,834 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
6,457 | $2,136,426 | |
| 6 | INSM |
INSMED Inc
|
9,808 | $1,603,803 | |
| 7 | GMAB |
Genmab A/S
This page
|
48,379 | $1,298,008 | |
| 8 | CYTK |
Cytokinetics Inc
|
17,069 | $1,125,017 |
All Filings in GMAB
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,298,008 | 48,379 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,222,975 | 39,707 | Shares | Defined | 2026-02-18 | |
| 2025-09-30 | $1,093,293 | 35,647 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $650,418 | 31,482 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $242,341 | 12,377 | Shares | Sole | 2025-05-15 | |
| 2024-09-30 | $204,499 | 8,388 | Shares | Defined | 2024-11-14 | |
| 2023-09-30 | $291,400 | 8,262 | Shares | Defined | 2024-02-21 | |
| No filing history on record for this holder in this stock. | ||||||